BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24885241)

  • 1. Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection.
    Linko R; Hedger MP; Pettilä V; Ruokonen E; Ala-Kokko T; Ludlow H; de Kretser DM
    BMC Infect Dis; 2014 May; 14():253. PubMed ID: 24885241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-binding protein (HBP) in critically ill patients with influenza A(H1N1) infection.
    Kaukonen KM; Linko R; Herwald H; Lindbom L; Ruokonen E; Ala-Kokko T; Pettilä V
    Clin Microbiol Infect; 2013 Dec; 19(12):1122-8. PubMed ID: 23402373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.
    Zogheib E; Nyga R; Cornu M; Sendid B; Monconduit J; Jounieaux V; Maizel J; Segard C; Chouaki T; Dupont H
    Lung; 2018 Feb; 196(1):65-72. PubMed ID: 29273833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza-induced acute respiratory distress syndrome during the 2010-2016 seasons: bacterial co-infections and outcomes by virus type and subtype.
    Bal A; Casalegno JS; Melenotte C; Daviet F; Ninove L; Edouard S; Morfin F; Valette M; De Lamballerie X; Lina B; Papazian L; Nougairède A; Hraiech S
    Clin Microbiol Infect; 2020 Jul; 26(7):947.e1-947.e4. PubMed ID: 32205296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critically ill patients with 2009 influenza A(H1N1) infection in Canada.
    Kumar A; Zarychanski R; Pinto R; Cook DJ; Marshall J; Lacroix J; Stelfox T; Bagshaw S; Choong K; Lamontagne F; Turgeon AF; Lapinsky S; Ahern SP; Smith O; Siddiqui F; Jouvet P; Khwaja K; McIntyre L; Menon K; Hutchison J; Hornstein D; Joffe A; Lauzier F; Singh J; Karachi T; Wiebe K; Olafson K; Ramsey C; Sharma S; Dodek P; Meade M; Hall R; Fowler RA;
    JAMA; 2009 Nov; 302(17):1872-9. PubMed ID: 19822627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study.
    de Kretser DM; Bensley JG; Pettilä V; Linko R; Hedger MP; Hayward S; Allan CA; McLachlan RI; Ludlow H; Phillips DJ
    Crit Care; 2013 Oct; 17(5):R263. PubMed ID: 24172607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.
    Hagau N; Slavcovici A; Gonganau DN; Oltean S; Dirzu DS; Brezoszki ES; Maxim M; Ciuce C; Mlesnite M; Gavrus RL; Laslo C; Hagau R; Petrescu M; Studnicska DM
    Crit Care; 2010; 14(6):R203. PubMed ID: 21062445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic values of serum activin-a levels in patients with acute respiratory distress syndrome.
    Kim JM; Lee JK; Choi SM; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
    BMC Pulm Med; 2019 Jun; 19(1):115. PubMed ID: 31238942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.
    Quispe-Laime AM; Bracco JD; Barberio PA; Campagne CG; Rolfo VE; Umberger R; Meduri GU
    Intensive Care Med; 2010 Jan; 36(1):33-41. PubMed ID: 19924393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia.
    Michel U; Ebert S; Phillips D; Nau R
    Eur J Endocrinol; 2003 May; 148(5):559-64. PubMed ID: 12720540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.
    Refaat B; Ashshi AM; El-Shemi AG; AlZanbagi A
    Clin Exp Med; 2015 Aug; 15(3):293-302. PubMed ID: 24925642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critically Ill patients with 2009 influenza A(H1N1) in Mexico.
    Domínguez-Cherit G; Lapinsky SE; Macias AE; Pinto R; Espinosa-Perez L; de la Torre A; Poblano-Morales M; Baltazar-Torres JA; Bautista E; Martinez A; Martinez MA; Rivero E; Valdez R; Ruiz-Palacios G; Hernández M; Stewart TE; Fowler RA
    JAMA; 2009 Nov; 302(17):1880-7. PubMed ID: 19822626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection.
    Miller RR; Markewitz BA; Rolfs RT; Brown SM; Dascomb KK; Grissom CK; Friedrichs MD; Mayer J; Hirshberg EL; Conklin J; Paine R; Dean NC
    Chest; 2010 Apr; 137(4):752-8. PubMed ID: 19933372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.
    Lin SD; Kawakami T; Ushio A; Sato A; Sato S; Iwai M; Endo R; Takikawa Y; Suzuki K
    J Gastroenterol Hepatol; 2006 Feb; 21(2):374-80. PubMed ID: 16509861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland.
    Linko R; Pettilä V; Ruokonen E; Varpula T; Karlsson S; Tenhunen J; Reinikainen M; Saarinen K; Perttilä J; Parviainen I; Ala-Kokko T;
    Acta Anaesthesiol Scand; 2011 Sep; 55(8):971-9. PubMed ID: 22092165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.
    ; Davies A; Jones D; Bailey M; Beca J; Bellomo R; Blackwell N; Forrest P; Gattas D; Granger E; Herkes R; Jackson A; McGuinness S; Nair P; Pellegrino V; Pettilä V; Plunkett B; Pye R; Torzillo P; Webb S; Wilson M; Ziegenfuss M
    JAMA; 2009 Nov; 302(17):1888-95. PubMed ID: 19822628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eighteen cases of 2009 influenza A H1N1 associated with respiratory failure in adults].
    Sun JJ; Li C; Wu DW; Li CH; Qin WH; Li YL; Liu QY; Li JX; Zou YG; Huang DQ; Xie JJ; Li EJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Mar; 22(3):156-60. PubMed ID: 20367906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum activin-A as a predictive and prognostic marker in critically ill patients with sepsis.
    Lee JK; Choi SM; Lee J; Park YS; Lee CH; Yim JJ; Yoo CG; Kim YW; Han SK; Lee SM
    Respirology; 2016 Jul; 21(5):891-7. PubMed ID: 26969968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.
    Álvarez-Lerma F; Marín-Corral J; Vila C; Masclans JR; González de Molina FJ; Martín Loeches I; Barbadillo S; Rodríguez A;
    Crit Care; 2016 Oct; 20(1):337. PubMed ID: 27770828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.